02/22/2024
7:00 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
7:07 AM | Edgewise Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
9:26 AM | Edgewise Therapeutics (Subject)
VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G/A | |
02/14/2024
7:43 AM | Deep Track Capital, LP (Filed by)
Edgewise Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
4:42 PM | Derakhshan Behrad (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
4:43 PM | Edgewise Therapeutics (Issuer)
MOORE JOHN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/07/2024
3:18 PM | Edgewise Therapeutics (Subject)
MOORE JOHN R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
02/01/2024
4:28 PM | Edgewise Therapeutics (Subject)
Flynn James E (Filed by)
| Form SC 13G/A | |
01/29/2024
3:30 PM | Edgewise Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G | |
01/23/2024
3:19 PM | Carruthers R Michael (Reporting)
Edgewise Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/19/2024
3:54 PM | Edgewise Therapeutics (Filer)
| Form 424B5 | |
01/19/2024
7:44 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/19/2024
5:02 AM | Edgewise Therapeutics (Filer)
| Form 424B3 | |
01/19/2024
5:04 AM | Edgewise Therapeutics (Filer)
| Form S-3MEF | |
01/19/2024
5:05 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/28/2023
3:38 PM | Edgewise Therapeutics (Issuer)
Russell Alan J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:39 PM | Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:39 PM | Edgewise Therapeutics (Issuer)
MOORE JOHN R (Reporting)
MOORE JOHN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:39 PM | Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
3:39 PM | Edgewise Therapeutics (Issuer)
Fox Jonathan C (Reporting)
Fox Jonathan C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2023
3:22 PM | Edgewise Therapeutics (Subject)
MOORE JOHN R (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2023
3:32 PM | Edgewise Therapeutics (Subject)
Russell Alan J (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/09/2023
7:00 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
7:05 AM | Edgewise Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/18/2023
6:12 PM | Edgewise Therapeutics (Issuer)
KOCH KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
6:13 PM | Donovan Joanne M. (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
6:13 PM | Edgewise Therapeutics (Issuer)
Semigran Marc (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
6:13 PM | Edgewise Therapeutics (Issuer)
Russell Alan J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
6:13 PM | Carruthers R Michael (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
6:13 PM | Edgewise Therapeutics (Issuer)
MOORE JOHN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/18/2023
6:13 PM | Derakhshan Behrad (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/10/2023
7:00 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2023
7:01 AM | Edgewise Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/14/2023
3:05 PM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/28/2023
3:17 PM | Edgewise Therapeutics (Subject)
Novo Holdings A/S (Filed by)
| Form SC 13D/A | |
06/26/2023
3:28 PM | Carruthers R Michael (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
8:57 PM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/16/2023
3:08 PM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
6:29 PM | Brege Laura (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
6:29 PM | Edgewise Therapeutics (Issuer)
Edris Badreddin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
6:29 PM | Edgewise Therapeutics (Issuer)
ROOT JONATHAN D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
How a $0.25 cent option contract makes my top traders feel (Ad) If you don’t know me, I’ve been in the markets for over 40 years… but recently, I’ve discovered a breakthrough that might be my favorite strategy of ALL time!
While I kept the finer details of these $0.25 Cent Trades under wraps until recently… Click now to see for yourself what $0.25 Cent Trades is all about |
06/14/2023
6:29 PM | Edgewise Therapeutics (Issuer)
Thompson Peter A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
6:30 PM | Edgewise Therapeutics (Issuer)
Fox Jonathan C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2023
7:01 AM | Edgewise Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/11/2023
7:00 AM | Edgewise Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2023
5:25 PM | Edgewise Therapeutics (Issuer)
KOCH KEVIN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2023
5:25 PM | Donovan Joanne M. (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2023
5:26 PM | Edgewise Therapeutics (Issuer)
Russell Alan J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2023
5:26 PM | Carruthers R Michael (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2023
5:26 PM | Edgewise Therapeutics (Issuer)
MOORE JOHN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2023
5:26 PM | Derakhshan Behrad (Reporting)
Edgewise Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/28/2023
3:10 PM | Edgewise Therapeutics (Filer)
| Form DEFA14A | |
